A detailed kinetic model of glycolysis in Plasmodium falciparum-infected red blood cells for antimalarial drug target identification.
Humans
Acidosis, Lactic
Antimalarials
/ pharmacology
Erythrocytes
/ drug effects
Glucose
/ metabolism
Glycolysis
/ drug effects
Hypoglycemia
Kinetics
Malaria, Falciparum
/ metabolism
Plasmodium falciparum
/ metabolism
Trophozoites
/ pathogenicity
Molecular Targeted Therapy
/ methods
Parasite Load
Models, Biological
glucose transport
glycolysis
malaria
mathematical modelling
red blood cell
systems biology
Journal
The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
received:
06
06
2023
revised:
11
07
2023
accepted:
23
07
2023
medline:
2
10
2023
pubmed:
31
7
2023
entrez:
30
7
2023
Statut:
ppublish
Résumé
Upon infection by the malaria parasite Plasmodium falciparum, the glycolytic rate of a red blood cell increases up to 100-fold, possibly contributing to lactic acidosis and hypoglycemia in patients with severe malaria. This dramatic increase in glucose uptake and metabolism was correctly predicted by a newly constructed detailed enzyme kinetic model of glucose metabolism in the trophozoite-infected red blood cell. Subsequently, we expanded the model to simulate an infected red blood cell culture, including the different asexual blood-stage forms of the malaria parasite. The model simulations were in good agreement with experimental data, for which the measured parasitic volume was an important parameter. Upon further analysis of the model, we identified glucose transport as a drug target that would specifically affect infected red blood cells, which was confirmed experimentally with inhibitor titrations. This model can be a first step in constructing a whole-body model for glucose metabolism in malaria patients to evaluate the contribution of the parasite's metabolism to the disease state.
Identifiants
pubmed: 37517694
pii: S0021-9258(23)02139-7
doi: 10.1016/j.jbc.2023.105111
pmc: PMC10474083
pii:
doi:
Substances chimiques
Antimalarials
0
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
105111Informations de copyright
Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article.